Gene · 91
Papers1,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept. | Diagnostics (Basel) | 2022 | 36611303 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| Demographic and Genome Wide Association Analyses According to Muscle Mass Using Data of the Korean Genome and Epidemiology Study. | J Korean Med Sci | 2022 | 36573383 | PubTator, text mining | PubMed |
| Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases. | Int J Mol Sci | 2022 | 36555754 | PubTator, text mining | PubMed |
| Activin A Modulates Betaglycan Shedding via the ALK4-SMAD3-Dependent Pathway in Endometriotic Cells. | Biomolecules | 2022 | 36551177 | PubTator, text mining | PubMed |
| Molecular signatures in the progression of COVID-19 severity. | Sci Rep | 2022 | 36543855 | PubTator, text mining | PubMed |
| SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. | J Exp Clin Cancer Res | 2022 | 36539767 | PubTator, text mining | PubMed |
| Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity. | Mil Med Res | 2022 | 36529792 | PubTator, text mining | PubMed |
| The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway. | Cancers (Basel) | 2022 | 36497429 | PubTator, text mining | PubMed |
| Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery. | Cancers (Basel) | 2022 | 36497286 | PubTator, text mining | PubMed |
| Follistatin Is a Novel Chemoattractant for Migration and Invasion of Placental Trophoblasts of Mice. | Cells | 2022 | 36497076 | PubTator, text mining | PubMed |
| Modeling Movement Disorders via Generation of hiPSC-Derived Motor Neurons. | Cells | 2022 | 36497056 | PubTator, text mining | PubMed |
| Chemokine signaling synchronizes angioblast proliferation and differentiation during pharyngeal arch artery vasculogenesis. | Development | 2022 | 36468454 | PubTator, text mining | PubMed |
| Myofibroblast specific targeting approaches to improve fibrosis treatment. | Chem Commun (Camb) | 2022 | 36445310 | PubTator, text mining | PubMed |
| Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. | Cell Commun Signal | 2022 | 36443839 | PubTator, text mining | PubMed |
| Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development. | Front Cardiovasc Med | 2022 | 36440002 | PubTator, text mining | PubMed |
| Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases. | Cells | 2022 | 36429069 | PubTator, text mining | PubMed |
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol. | BMJ Open | 2022 | 36400733 | PubTator, text mining | PubMed |
| Elevated plasma miR-210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development. | Mol Genet Genomic Med | 2022 | 36369742 | PubTator, text mining | PubMed |
| miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC. | Cancers (Basel) | 2022 | 36358691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91/papers?page=12